Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

被引：1553

作者：

Smith, BR

Cooper, DS

Doherty, GM

Haugen, BR

Kloos, RT

Lee, SL

Mandel, SJ

Mazzaferri, EL

McIver, B

Sherman, SI

Tuttle, RM

机构：

[1] Sinai Hosp Baltimore, Baltimore, MD USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[3] Univ Michigan, Med Ctr, Ann Arbor, MI USA

[4] Univ Colorado, Hlth Sci Ctr, Denver, CO USA

[5] Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA

[6] Boston Univ, Med Ctr, Boston, MA USA

[7] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

[8] Univ Florida, Coll Med, Gainesville, FL USA

[9] Mayo Clin, Rochester, MN USA

[10] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[11] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

THYROID | 2006年 / 16卷 / 02期

关键词：

D O I：

10.1089/thy.2006.16.109

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：109 / +

页数：31

共 312 条

[61] Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy [J].

Dupuy, DE ;

Monchik, JM ;

Decrea, C ;

Pisharodi, L .

SURGERY, 2001, 130 (06) :971-977

[62] MEASUREMENT OF SERUM TSH AND THYROID-HORMONES IN MANAGEMENT OF TREATMENT OF THYROID-CARCINOMA WITH RADIOIODINE [J].

EDMONDS, CJ ;

KERMODE, JC ;

HAYES, S ;

THOMPSON, BD .

BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (599) :799-807

[63] Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders [J].

Elisei, R ;

Bottici, V ;

Luchetti, F ;

Di Coscio, G ;

Romei, C ;

Grasso, L ;

Miccoli, P ;

Iacconi, P ;

Basolo, F ;

Pinchera, A ;

Pacini, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :163-168

[64] Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients [J].

Elisei, R ;

Vivaldi, A ;

Agate, L ;

Molinaro, E ;

Nencetti, C ;

Grasso, L ;

Pinchera, A ;

Pacini, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :33-39

[65] Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma [J].

Erdem, E ;

Gülçelik, MA ;

Kuru, B ;

Alagöl, H .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (09) :747-749

[66] Value of re-aspirations in benign nodular thyroid disease [J].

Erdogan, MF ;

Kamel, N ;

Aras, D ;

Akdogan, A ;

Baskal, N ;

Erdogan, G .

THYROID, 1998, 8 (12) :1087-1090

[67] Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis [J].

Esnaola, NF ;

Cantor, SB ;

Sherman, SI ;

Lee, JE ;

Evans, DB .

SURGERY, 2001, 130 (06) :921-930

[68] Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma [J].

Eustatia-Rutten, CFA ;

Romijn, JA ;

Guijt, MJ ;

Vielvoye, GJ ;

van den Berg, R ;

Corssmit, EPM ;

Pereira, AM ;

Smit, JWA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3184-3189

[69] Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis [J].

Eustatia-Rutten, CFA ;

Smit, JWA ;

Romijn, JA ;

van der Kleij-Corssmit, EPM ;

Pereira, AM ;

Stokkel, MP ;

Kievit, J .

CLINICAL ENDOCRINOLOGY, 2004, 61 (01) :61-74

[70] Lack of impact of radioiodine therapy in Tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer [J].

Fatourechi, V ;

Hay, ID ;

Javedan, H ;

Wiseman, GA ;

Mullan, BP ;

Gorman, CA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1521-1526

← 2 3 4 5 6 7 8 9 10 11 →